The most important financial indicators for the company Endocrin Diagnostic Si Tratament S.r.l. - Unique Identification Number 7713958:
sales in 2023 was
83.882
euro, registering a net profit of
6.001
euro and having an average number of
4
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 37.6%, from 61.147 euro in the year 2022, to 83.882 euro in 2023.
The Net Profit decreased by -6.678 euro, from 12.718 euro in 2022, to 6.001 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Endocrin Diagnostic Si Tratament S.r.l. - CUI 7713958
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
3.520
1.732
929
317
1.085
938
1.968
1.373
825
414
Current Assets
596
423
666
716
1.394
7.217
17.727
9.670
15.070
22.881
Inventories
0
0
0
0
75
0
0
0
0
340
Receivables
286
118
102
344
395
1.622
2.654
443
452
1.946
Cash
310
306
564
372
925
5.595
15.073
9.227
14.618
20.594
Shareholders Funds
-23.293
-34.946
-20.269
-13.323
-13.613
5.016
17.446
5.703
12.767
18.729
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
27.409
37.101
21.863
14.356
16.093
3.139
2.249
5.340
3.128
4.566
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
22.881 euro in 2023 which includes Inventories of
340 euro, Receivables of
1.946 euro and cash availability of
20.594 euro.
The company's Equity was valued at
18.729 euro, while total Liabilities amounted to
4.566 euro.
Equity increased by 6.001 euro, from 12.767 euro in 2022, to 18.729 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Endocrin Diagnostic Si Tratament S.r.l.